Literature DB >> 5558186

Relationship between plasma level and therapeutic effect of nortriptyline.

M Asberg, B Crönholm, F Sjöqvist, D Tuck.   

Abstract

The relationship between plasma concentration of nortriptyline and therapeutic effect after two weeks' treatment with the drug was investigated in 29 psychiatric inpatients. Endogenous depression was diagnosed in all patients. Amelioration of depressive symptoms was estimated as reduction in score on a rating scale, based on a psychiatric interview. Amelioration was not correlated to the patient's sex or age. There was a curved relationship between plasma level of nortriptyline and therapeutic effect. Amelioration was most pronounced in the intermediate plasma level range (50-139 ng nortriptyline/ml plasma) and was slight both at lower and at higher plasma levels. This type of relationship may be due to the dual action of tricyclic antidepressants which has been found in animal experiments. On larger dosages a phenothiazine-like blockade of the monoaminergic receptor is added to the blockade of monoamine reuptake thought to be related to the antidepressant action of the drugs.THIS STUDY THUS SUGGESTS TWO POSSIBLE REASONS FOR A THERAPEUTIC FAILURE WITH NORTRIPTYLINE: a too low or a too high plasma level. The large individual variation in the pharmacokinetics of the tricyclic antidepressants makes prediction of plasma level from dosage in a given individual virtually impossible without knowledge of rate of elimination and apparent volume of distribution. Hence monitoring plasma levels may be a way to increase the efficacy of treatment with these drugs.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5558186      PMCID: PMC1798656          DOI: 10.1136/bmj.3.5770.331

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  2 in total

1.  Steady-state plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy.

Authors:  B Alexanderson; D A Evans; F Sjöqvist
Journal:  Br Med J       Date:  1969-12-27

Review 2.  Biogenic amines and emotion.

Authors:  J J Schildkraut; S S Kety
Journal:  Science       Date:  1967-04-07       Impact factor: 47.728

  2 in total
  91 in total

1.  Optimal sampling times for Bayesian estimation of the pharmacokinetic parameters of nortriptyline during therapeutic drug monitoring.

Authors:  Y Merlé; F Mentré
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

2.  Comprehensive survey of the relationship between serum concentration and therapeutic effect of amitriptyline in depression.

Authors:  Sven Ulrich; Jürgen Läuter
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

3.  The "top 50": a perspective on the BMJ drawn from the Science Citation Index.

Authors:  B Dixon
Journal:  BMJ       Date:  1990-10-03

4.  The effect of fluphenazine on steady state plasma levels of nortriptyline.

Authors:  I H Stevenson; A A Schiff
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

5.  Plasma concentrations of tricyclic antidepressive drugs.

Authors:  M Lader
Journal:  Br J Clin Pharmacol       Date:  1974-08       Impact factor: 4.335

6.  Self-inhibiting action of nortriptyline's anti-immobility effect at high plasma and brain levels in mice.

Authors:  I Reis de Oliveria; B Diquet; V Van der Meersch; R Dardennes; J Gonidec; P A do Prado-Lima
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Tricyclic antidepressant plasma level monitoring: intraindividual variability in everyday practice.

Authors:  S Vandel; G Bertschy; S Nezeloff; B Bonin; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 8.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 9.  The Role of Metabolites of Antidepressants in the Treatment of Depression.

Authors:  M V Rudorfer; W Z Potter
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

10.  The pharmacokinetics of nortriptyline in patients with chronic renal failure.

Authors:  S Dawlilng; K Lynn; R Rosser; R Braithwaite
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.